Current Status of Endovascular Treatment for Acute Large Vessel Occlusion in China
Baixue Jia,Zeguang Ren,Maxim Mokin,W. Scott Burgin,Clayton T. Bauer,Jens Fiehler,Dapeng Mo,Ning Ma,Feng Gao,Xiaochuan Huo,Gang Luo,Anxin Wang,Yuesong Pan,Ligang Song,Xuan Sun,Xuelei Zhang,Liqiang Gui,Cunfeng Song,Ya Peng,Jin Wu,Shijun Zhao,Junfeng Zhao,Zhiming Zhou,Yongli Li,Ping Jing,Lei Yang,Yajie Liu,Qingshi Zhao,Yan Liu,Xiaoxiang Peng,Qingchun Gao,Zaiyu Guo,Wenhuo Chen,Weirong Li,Xiaojiang Cheng,Yun Xu,Yongqiang Zhang,Guilian Zhang,Yijiu Lu,Xinyu Lu,Dengxiang Wang,Yan Wang,Hao Li,Li Ling,Guangge Peng,Jingyu Zhang,Kai Zhang,Shuo Li,Zhongqi Qi,Haifeng Xu,Xu Tong,Gaoting Ma,Raynald Liu,Xu Guo,Yiming Deng,Xinyi Leng,Thomas W. Leung,David S. Liebeskind,Yilong Wang,Yongjun Wang,Zhongrong Miao,Yang Hua,Deqin Geng,Haicheng Yuan,Hongwei Wang,Haihua Yang,Zengwu Wang,Liping Wei,Xuancong Liufu,Xiangqun Shi,Juntao Li,Wenwu Yang,Wenji Jing,Xiang Yong,Leyuan Wang,Chunlei Li,Yibin Cao,Qingfeng Zhu,Peng Zhang,Xiang Luo,Shengli Chen,WenWu Peng,Lixin Wang,Xue Wen,Shugui Shi,Wanming Wang,Wang Bo,Pu Yuan,Dong Wang,Haitao Guan,Wenbao Liang,Daliang Ma,Long Chen,Yan Xiao,Xiangdong Xie,Zhonghua Shi,Xiangjun Zeng,Fanfan Su,MingZe Chang,Jijun Yin,Hongxia Sun,Chong Li,Yong Bi,Gang Xie,Yuwu Zhao,Chao Wang,Peng Zhang,Xianjun Wang,Dongqun Li,Hui Liang,Zhonglun Chen,Yu Xin Wang,Lin Yin,HongKai Qiu,Jun Wei,Yaxuan Sun,Xiaoya Feng,Weihua Wu,Lianbo Gao,Zhibing Ai,Tan Lan,Li Ding,Qilong Liang,Zhimin Wang,Jianwen Yang,Ping Xu,Wei Dong,Quanle Zheng,Zhenyun Zhu,Liyue Zhao,Qingbo Meng,Yuqing Wei,Xianglin Chen,Wei Wang,Dong Sun,Yongxing Yan,Guangxiong Yuan,Yadong Yang,Jianfeng Zhou,Zhi Yang,Zhenzhong Zhang,Ning Guan,Huihong Wang
DOI: https://doi.org/10.1161/strokeaha.120.031869
IF: 10.17
2021-04-01
Stroke
Abstract:Background and Purpose: The benefit of endovascular treatment (EVT) for large vessel occlusion in clinical practice in developing countries like China needs to be confirmed. The aim of the study was to determine whether the benefit of EVT for acute ischemic stroke in randomized trials could be generalized to clinical practice in Chinese population. Methods: We conducted a prospective registry of EVT at 111 centers in China. Patients with acute ischemic stroke caused by imaging-confirmed intracranial large vessel occlusion and receiving EVT were included. The primary outcome was functional independence at 90 days defined as a modified Rankin Scale score of 0 to 2. Outcomes of specific subgroups in the anterior circulation were reported and logistic regression was performed to predict the primary outcome. Results: Among the 1793 enrolled patients, 1396 (77.9%) had anterior circulation large vessel occlusion (median age, 66 [56–73] years) and 397 (22.1%) had posterior circulation large vessel occlusion (median age, 64 [55–72] years). Functional independence at 90 days was reached in 45% and 44% in anterior and posterior circulation groups, respectively. For anterior circulation population, underlying intracranial atherosclerotic disease was identified in 29% of patients, with higher functional independence at 90 days (52% versus 44%; P =0.0122) than patients without intracranial atherosclerotic disease. In the anterior circulation population, after adjusting for baseline characteristics, procedure details, and early outcomes, the independent predictors for functional independence at 90 days were age 6 hours (OR, 1.536 [95% CI, 1.065–2.216]), local anesthesia (OR, 2.194 [95% CI, 1.325–3.633]), final modified Thrombolysis in Cerebral Infarction 2b/3 (OR, 2.052 [95% CI, 1.085–3.878]), puncture-to-reperfusion time ≤1.5 hours (OR, 1.628 [95% CI, 1.098–2.413]), and National Institutes of Health Stroke Scale score 24 hours after the procedure <11 (OR, 9.126 [95% CI, 6.222–13.385]). Conclusions: Despite distinct characteristics in the Chinese population, favorable outcome of EVT can be achieved in clinical practice in China. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03370939.
peripheral vascular disease,clinical neurology